Cargando…
A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates
Non-alcoholic steatohepatitis (NASH) is a progressive and severe liver disease, characterized by lipid accumulation, inflammation, and downstream fibrosis. Despite its increasing prevalence, there is no approved treatment yet available for patients. This has been at least partially due to the lack o...
Autores principales: | Ströbel, Simon, Kostadinova, Radina, Fiaschetti-Egli, Katia, Rupp, Jana, Bieri, Manuela, Pawlowska, Agnieszka, Busler, Donna, Hofstetter, Thomas, Sanchez, Katarzyna, Grepper, Sue, Thoma, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611054/ https://www.ncbi.nlm.nih.gov/pubmed/34815444 http://dx.doi.org/10.1038/s41598-021-01951-7 |
Ejemplares similares
-
Nitro-oleic acid as a new drug candidate for non-alcoholic steatohepatitis
por: Yang, Rui-Xu, et al.
Publicado: (2019) -
Combined alcoholic and non-alcoholic steatohepatitis
por: Ntandja Wandji, Line Carolle, et al.
Publicado: (2020) -
ω‐Imidazolyl‐alkyl derivatives as new preclinical drug candidates for treating non‐alcoholic steatohepatitis
por: Diesinger, Torsten, et al.
Publicado: (2021) -
Fructose and Non-Alcoholic Steatohepatitis
por: Roeb, Elke, et al.
Publicado: (2021) -
Statins in Non-alcoholic Steatohepatitis
por: Torres-Peña, Jose D., et al.
Publicado: (2021)